ResMed (RMD) PT Raised to $250 at Wolfe Research

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 1/30/2023

1. TSLA
2. GM
3. CL
4. SCHW
5. EMN

6. AMZN
7. META
8. SOFI
9. SPY
10. CHTR

August 12, 2022 5:06 AM EDT

Price: $222.71 -0.84%

Rating Summary:
12 Buy, 10 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
Up: 18 | Down: 24 | New: 19

Wolfe Research analyst Mike Polark raised the price target on ResMed (NYSE: RMD) to $250.00 (from $230.00) while maintaining a Outperform rating.

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!